Timing and Causes of Readmission After Acute Heart Failure Hospitalization—Insights From the Heart Failure Network Trials
Justin Vader, Lisa de las Fuentes(Washington University in St. Louis), Anuradha Lala(NewYork–Presbyterian Hospital), Justin L. Grodin(The University of Texas Southwestern Medical Center), Shane LaRue(Washington University in St. Louis), Víctor G. Dávila‐Román(Washington University in St. Louis), Susanna R. Stevens(Mayo Clinic), Robert J. Mentz(Duke University), Omar F. AbouEzzeddine(Mayo Clinic), Shannon M. Dunlay(Mayo Clinic), Adam D. DeVore(Duke University), John D. Groarke(Edinburgh Cancer Research)
Cited by 99
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k